Bajaj HealthCare Limited (BAJAJHCARE.NS)
INR 569.3
(-4.08%)
INR 569.3
(-4.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.65 Billion INR | -15.12% |
| 2022 | 9.01 Billion INR | 25.01% |
| 2021 | 7.21 Billion INR | 37.19% |
| 2020 | 5.25 Billion INR | 61.36% |
| 2019 | 3.25 Billion INR | 22.07% |
| 2018 | 2.66 Billion INR | -0.48% |
| 2017 | 2.68 Billion INR | 22.3% |
| 2016 | 2.19 Billion INR | 4.89% |
| 2015 | 2.09 Billion INR | 43.31% |
| 2014 | 1.45 Billion INR | 0.3% |
| 2013 | 1.45 Billion INR | 11.01% |
| 2012 | 1.31 Billion INR | 7.83% |
| 2011 | 1.21 Billion INR | 17.36% |
| 2010 | 1.03 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 7.65 Billion INR | 0.0% |
| 2023 FY | 7.65 Billion INR | -15.12% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 8.37 Billion INR | 0.0% |
| 2022 Q2 | 8.25 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 9.01 Billion INR | 25.01% |
| 2022 Q4 | 9.01 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 FY | 7.21 Billion INR | 37.19% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 6.56 Billion INR | 0.0% |
| 2021 Q4 | 7.21 Billion INR | 0.0% |
| 2020 Q2 | 4.27 Billion INR | 0.0% |
| 2020 Q4 | 5.25 Billion INR | 0.0% |
| 2020 FY | 5.25 Billion INR | 61.36% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q2 | 2.8 Billion INR | 0.0% |
| 2019 FY | 3.25 Billion INR | 22.07% |
| 2019 Q4 | 3.25 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 2.82 Billion INR | 5.96% |
| 2018 Q2 | 2.76 Billion INR | 0.0% |
| 2018 Q3 | 2.66 Billion INR | -3.4% |
| 2018 FY | 2.66 Billion INR | -0.48% |
| 2018 Q1 | 2.76 Billion INR | 3.02% |
| 2017 Q1 | 2.45 Billion INR | 11.9% |
| 2017 Q2 | 2.45 Billion INR | 0.0% |
| 2017 Q3 | 2.68 Billion INR | 9.29% |
| 2017 Q4 | 2.68 Billion INR | 0.0% |
| 2017 FY | 2.68 Billion INR | 22.3% |
| 2016 Q3 | 2.19 Billion INR | 1.41% |
| 2016 Q2 | 2.16 Billion INR | 0.0% |
| 2016 Q4 | 2.19 Billion INR | 0.0% |
| 2016 FY | 2.19 Billion INR | 4.89% |
| 2016 Q1 | 2.16 Billion INR | 3.43% |
| 2015 Q2 | 1.65 Billion INR | 0.0% |
| 2015 Q4 | 2.09 Billion INR | 30.08% |
| 2015 Q3 | 1.6 Billion INR | -2.92% |
| 2015 Q1 | 1.65 Billion INR | 0.0% |
| 2015 FY | 2.09 Billion INR | 43.31% |
| 2014 FY | 1.45 Billion INR | 0.3% |
| 2013 FY | 1.45 Billion INR | 11.01% |
| 2012 FY | 1.31 Billion INR | 7.83% |
| 2011 FY | 1.21 Billion INR | 17.36% |
| 2010 FY | 1.03 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 88.129% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -418.093% |
| FDC Limited | 24.68 Billion INR | 68.999% |
| Gufic Biosciences Limited | 10.92 Billion INR | 29.968% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 93.375% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 65.08% |
| Orchid Pharma Limited | 15.53 Billion INR | 50.76% |
| Alkem Laboratories Limited | 155.74 Billion INR | 95.087% |
| Brooks Laboratories Limited | 904.45 Million INR | -745.955% |
| Eris Lifesciences Limited | 70.48 Billion INR | 89.145% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 73.157% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 67.394% |
| Innova Captab Limited | 13.2 Billion INR | 42.074% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -252.467% |
| Wanbury Limited | 3.43 Billion INR | -122.749% |
| Lupin Limited | 239.97 Billion INR | 96.812% |
| Aarti Drugs Limited | 24.32 Billion INR | 68.544% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 70.368% |
| Albert David Limited | 4.97 Billion INR | -53.643% |
| Alembic Limited | 23.28 Billion INR | 67.145% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -1525.072% |
| Hester Biosciences Limited | 6.62 Billion INR | -15.518% |
| Hikal Limited | 24.87 Billion INR | 69.237% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 34.33% |
| Ind-Swift Limited | 6.54 Billion INR | -16.908% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 65.909% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -218.721% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | -9.259% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -129.476% |
| Medico Remedies Limited | 961.95 Million INR | -695.39% |
| Morepen Laboratories Limited | 12.93 Billion INR | 40.835% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 3.68% |
| RPG Life Sciences Limited | 5.12 Billion INR | -49.186% |
| Sigachi Industries Limited | 6.94 Billion INR | -10.224% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.105% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 66.056% |
| Themis Medicare Limited | 5.66 Billion INR | -35.082% |
| Unichem Laboratories Limited | 31.69 Billion INR | 75.858% |
| Vaishali Pharma Limited | 799.55 Million INR | -856.94% |
| Venus Remedies Limited | 6.26 Billion INR | -22.063% |
| Windlas Biotech Limited | 6.26 Billion INR | -22.185% |
| ZIM Laboratories Limited | 4.46 Billion INR | -71.238% |
| Sakar Healthcare Limited | 3.88 Billion INR | -96.863% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 98.302% |
| Divi's Laboratories Limited | 154.7 Billion INR | 95.054% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 29.025% |
| Mankind Pharma Limited | 119.63 Billion INR | 93.604% |
| Sequent Scientific Limited | 15.4 Billion INR | 50.329% |
| Laurus Labs Limited | 83.87 Billion INR | 90.877% |
| Neuland Laboratories Limited | 18.32 Billion INR | 58.248% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 80.844% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 94.671% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 97.387% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -108.555% |
| Wockhardt Limited | 76.49 Billion INR | 89.997% |
| Bal Pharma Limited | 3.2 Billion INR | -138.812% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 98.026% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 36.968% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -652.996% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 71.634% |
| Shilpa Medicare Limited | 30.93 Billion INR | 75.264% |
| Valiant Laboratories Limited | 3.42 Billion INR | -123.273% |
| Ajanta Pharma Limited | 46.38 Billion INR | 83.504% |
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -150.868% |
| Granules India Limited | 55.2 Billion INR | 86.141% |
| Medicamen Biotech Limited | 2.94 Billion INR | -159.786% |
| Ipca Laboratories Limited | 111.01 Billion INR | 93.108% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -89.077% |
| Piramal Enterprises Limited | 826.05 Billion INR | 99.074% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 94.92% |
| NATCO Pharma Limited | 69.06 Billion INR | 88.921% |
| Suven Life Sciences Limited | 2.84 Billion INR | -168.558% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -329.426% |
| Strides Pharma Science Limited | 58.39 Billion INR | 86.898% |
| Indoco Remedies Limited | 21.44 Billion INR | 64.325% |
| Alpa Laboratories Limited | 1.82 Billion INR | -318.969% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -407.148% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -48.557% |